A detailed history of Leibman Financial Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Leibman Financial Services, Inc. holds 11,982 shares of AMGN stock, worth $3.15 Million. This represents 2.74% of its overall portfolio holdings.

Number of Shares
11,982
Previous 12,530 4.37%
Holding current value
$3.15 Million
Previous $3.92 Billion 1.39%
% of portfolio
2.74%
Previous 2.9%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$309.38 - $337.38 $169,540 - $184,884
-548 Reduced 4.37%
11,982 $3.86 Billion
Q2 2024

Jul 08, 2024

BUY
$262.75 - $319.31 $126,382 - $153,588
481 Added 3.99%
12,530 $3.92 Billion
Q1 2024

Apr 04, 2024

BUY
$268.87 - $324.56 $81,467 - $98,341
303 Added 2.58%
12,049 $3.43 Billion
Q4 2023

Jan 05, 2024

BUY
$255.7 - $288.46 $3 Million - $3.39 Million
11,746 New
11,746 $3.38 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Leibman Financial Services, Inc. Portfolio

Follow Leibman Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leibman Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Leibman Financial Services, Inc. with notifications on news.